FdaApplication
NDA 205879
Identifiers
- fda_app_no: NDA205879
Properties
| Property | Value |
|---|---|
| applicant_name | JANSSEN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2016-09-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| INVOKAMET XR | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 50MG;500MG | TABLET, EXTENDED RELEASE;ORAL |
| INVOKAMET XR | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 150MG;1GM | TABLET, EXTENDED RELEASE;ORAL |
| INVOKAMET XR | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 150MG;500MG | TABLET, EXTENDED RELEASE;ORAL |
| INVOKAMET XR | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 50MG;1GM | TABLET, EXTENDED RELEASE;ORAL |
4 products